Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi-hit hypothesis

Abstract Central Nervous System inflammation has been implicated in neurodegenerative disorders including Parkinson’s disease (Ransohoff, Science 353: 777–783, 2016; Kannarkat et al. J. Parkinsons Dis. 3: 493–514, 2013). Here, we examined if the H1N1 influenza virus (Studahl et al. Drugs 73: 131–158...

Full description

Bibliographic Details
Main Authors: Shankar Sadasivan, Bridgett Sharp, Stacey Schultz-Cherry, Richard Jay Smeyne
Format: Article
Language:English
Published: Nature Portfolio 2017-05-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-017-0019-z
_version_ 1797428210853478400
author Shankar Sadasivan
Bridgett Sharp
Stacey Schultz-Cherry
Richard Jay Smeyne
author_facet Shankar Sadasivan
Bridgett Sharp
Stacey Schultz-Cherry
Richard Jay Smeyne
author_sort Shankar Sadasivan
collection DOAJ
description Abstract Central Nervous System inflammation has been implicated in neurodegenerative disorders including Parkinson’s disease (Ransohoff, Science 353: 777–783, 2016; Kannarkat et al. J. Parkinsons Dis. 3: 493–514, 2013). Here, we examined if the H1N1 influenza virus (Studahl et al. Drugs 73: 131–158, 2013) could synergize with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Jackson-Lewis et al. in Mark LeDoux (ed) Movement Disorders: Genetics and Models: 287–306, Elsevier, 2015) to induce a greater microglial activation and loss of substantia nigra pars compacta dopaminergic neurons than either insult alone. H1N1-infected animals administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exhibit a 20% greater loss of substantia nigra pars compacta dopaminergic neurons than occurs from the additive effects of H1N1 or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine alone (p < 0.001). No synergistic effects were found in microglial activation. The synergistic dopaminergic neuron loss is eliminated by influenza vaccination or treatment with oseltamivir carboxylate. This work shows that multiple insults can induce synergistic effects; and even these small changes can be significant as it might allow one to cross a phenotypic disease threshold that would not occur from individual non-interacting exposures. Our observations also have important implications for public health, providing impetus for influenza vaccination or prompt treatment with anti-viral medications upon influenza diagnosis.
first_indexed 2024-03-09T08:55:48Z
format Article
id doaj.art-0369d5d90ad74a1cad2a21eccde46e28
institution Directory Open Access Journal
issn 2373-8057
language English
last_indexed 2024-03-09T08:55:48Z
publishDate 2017-05-01
publisher Nature Portfolio
record_format Article
series npj Parkinson's Disease
spelling doaj.art-0369d5d90ad74a1cad2a21eccde46e282023-12-02T13:09:15ZengNature Portfolionpj Parkinson's Disease2373-80572017-05-01311310.1038/s41531-017-0019-zSynergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi-hit hypothesisShankar Sadasivan0Bridgett Sharp1Stacey Schultz-Cherry2Richard Jay Smeyne3Department of Developmental Neurobiology, St. Jude Children’s Research HospitalDepartment of Infectious Diseases, St. Jude Children’s Research HospitalDepartment of Infectious Diseases, St. Jude Children’s Research HospitalDepartment of Developmental Neurobiology, St. Jude Children’s Research HospitalAbstract Central Nervous System inflammation has been implicated in neurodegenerative disorders including Parkinson’s disease (Ransohoff, Science 353: 777–783, 2016; Kannarkat et al. J. Parkinsons Dis. 3: 493–514, 2013). Here, we examined if the H1N1 influenza virus (Studahl et al. Drugs 73: 131–158, 2013) could synergize with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Jackson-Lewis et al. in Mark LeDoux (ed) Movement Disorders: Genetics and Models: 287–306, Elsevier, 2015) to induce a greater microglial activation and loss of substantia nigra pars compacta dopaminergic neurons than either insult alone. H1N1-infected animals administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exhibit a 20% greater loss of substantia nigra pars compacta dopaminergic neurons than occurs from the additive effects of H1N1 or 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine alone (p < 0.001). No synergistic effects were found in microglial activation. The synergistic dopaminergic neuron loss is eliminated by influenza vaccination or treatment with oseltamivir carboxylate. This work shows that multiple insults can induce synergistic effects; and even these small changes can be significant as it might allow one to cross a phenotypic disease threshold that would not occur from individual non-interacting exposures. Our observations also have important implications for public health, providing impetus for influenza vaccination or prompt treatment with anti-viral medications upon influenza diagnosis.https://doi.org/10.1038/s41531-017-0019-z
spellingShingle Shankar Sadasivan
Bridgett Sharp
Stacey Schultz-Cherry
Richard Jay Smeyne
Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi-hit hypothesis
npj Parkinson's Disease
title Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi-hit hypothesis
title_full Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi-hit hypothesis
title_fullStr Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi-hit hypothesis
title_full_unstemmed Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi-hit hypothesis
title_short Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi-hit hypothesis
title_sort synergistic effects of influenza and 1 methyl 4 phenyl 1 2 3 6 tetrahydropyridine mptp can be eliminated by the use of influenza therapeutics experimental evidence for the multi hit hypothesis
url https://doi.org/10.1038/s41531-017-0019-z
work_keys_str_mv AT shankarsadasivan synergisticeffectsofinfluenzaand1methyl4phenyl1236tetrahydropyridinemptpcanbeeliminatedbytheuseofinfluenzatherapeuticsexperimentalevidenceforthemultihithypothesis
AT bridgettsharp synergisticeffectsofinfluenzaand1methyl4phenyl1236tetrahydropyridinemptpcanbeeliminatedbytheuseofinfluenzatherapeuticsexperimentalevidenceforthemultihithypothesis
AT staceyschultzcherry synergisticeffectsofinfluenzaand1methyl4phenyl1236tetrahydropyridinemptpcanbeeliminatedbytheuseofinfluenzatherapeuticsexperimentalevidenceforthemultihithypothesis
AT richardjaysmeyne synergisticeffectsofinfluenzaand1methyl4phenyl1236tetrahydropyridinemptpcanbeeliminatedbytheuseofinfluenzatherapeuticsexperimentalevidenceforthemultihithypothesis